OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network
Youjun She, Zihan Guo, Qing Zhai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Youjun She, Zihan Guo, Qing Zhai, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Showing 6 citing articles:
A disproportionality analysis of CDK4/6 inhibitors in the FDA adverse event reporting system (FAERS)
Yuan Peng, Yuying Zhou, Xuanyi Zhou, et al.
Expert Opinion on Drug Safety (2024), pp. 1-9
Open Access | Times Cited: 4
Yuan Peng, Yuying Zhou, Xuanyi Zhou, et al.
Expert Opinion on Drug Safety (2024), pp. 1-9
Open Access | Times Cited: 4
Hepatic Adverse Events with CDK4/6 Inhibitors: A systematic review combining meta-analysis and FAERS Database
Yuyao Tang, Yongxin Li, Cheng-Rong Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Yuyao Tang, Yongxin Li, Cheng-Rong Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
CDK4/6 Inhibitors in Patients with Breast Cancer: A Review of Adverse Event Profiles and Recommendations for Supportive Care Interventions
Kathryn Post, Mia Holtze, Steven J. Isakoff, et al.
Current Breast Cancer Reports (2025) Vol. 17, Iss. 1
Closed Access
Kathryn Post, Mia Holtze, Steven J. Isakoff, et al.
Current Breast Cancer Reports (2025) Vol. 17, Iss. 1
Closed Access
A real-world drug safety surveillance study from the FAERS database of breast cancer patients receiving abemaciclib alone and plus letrozole
Lu Hu, Yong Ran, Chunqiao Zhou, et al.
Research Square (Research Square) (2025)
Closed Access
Lu Hu, Yong Ran, Chunqiao Zhou, et al.
Research Square (Research Square) (2025)
Closed Access
Unveiling esophageal cancer treatment mechanisms: network pharmacology and molecular docking of Physcion
Guangbing Hu, Haiyang Guo, Liuyi Lu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Guangbing Hu, Haiyang Guo, Liuyi Lu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Ribociclib-induced autoimmune-like hepatitis: a case report
Gözde Kavgacı, Taha Koray Şahin, Cenk Sökmensüer, et al.
Journal of Chemotherapy (2024), pp. 1-6
Closed Access
Gözde Kavgacı, Taha Koray Şahin, Cenk Sökmensüer, et al.
Journal of Chemotherapy (2024), pp. 1-6
Closed Access
